What is the MELISA (Memory Lymphocyte Immuno‑Stimulation Assay) blood test?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 22, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

What is the MELISA Blood Test?

MELISA (Memory Lymphocyte ImmunoStimulation Assay) is a specialized lymphocyte transformation test marketed for detecting metal hypersensitivity, but the evidence shows it is neither sensitive nor specific for diagnosing metal allergy or associated chronic diseases, and it is not recommended for clinical use.

Test Description

MELISA is an in vitro blood test that measures lymphocyte proliferation in response to various metals (including aluminum, nickel, mercury, gold, palladium, titanium, and others). The test works by:

  • Exposing a patient's lymphocytes to different metal concentrations
  • Measuring cellular proliferation as an indicator of immune sensitization
  • Calculating a "Stimulation Index" to determine reactivity 1, 2

The test was originally developed to screen for allergenic epitopes of drugs and chemicals, then adapted for metal sensitivity testing 3.

Critical Evidence Against Clinical Use

Lack of Sensitivity and Specificity

The most recent and rigorous study (2017) demonstrated that MELISA is neither sensitive nor specific for detecting metal hypersensitivity. In 16 patients with suspected autoimmune/inflammatory syndrome, only 9 showed any metal reactivity, with 7 patients testing completely negative despite clinical suspicion 4. This represents a 44% false-negative rate in a symptomatic population.

High False-Positive Rate

A 2005 Dutch medical journal review concluded that MELISA produces a high number of false-positive results, rendering it useless for diagnosing metal allergy 5. The claims that metal allergy plays a role in immune-mediated diseases, metabolic disorders, and neurological conditions lack sound scientific evidence 5.

Reproducibility Issues

While proponents claim 94% reproducibility 1, 2, this varies significantly based on:

  • Lymphocyte concentration (higher concentrations produce stronger reactions regardless of true sensitivity)
  • Mercury concentrations >0.5 μg/ml cause non-specific mitogenic reactions
  • Absolute Stimulation Index values vary between tests, though qualitative results may be more consistent 2

Why This Test Is Not Recommended

Standard patch testing remains the gold standard for diagnosing metal allergy, particularly for contact dermatitis and delayed hypersensitivity reactions 6. Unlike MELISA:

  • Patch testing has established sensitivity and specificity
  • Results correlate with clinical outcomes
  • It is included in evidence-based allergy guidelines 6

Common Pitfalls to Avoid

  1. Do not order MELISA for suspected metal allergy - Use validated patch testing instead
  2. Do not use MELISA results to guide dental restoration removal - Clinical correlation with patch testing is more appropriate
  3. Do not attribute chronic fatigue, autoimmune diseases, or neurological symptoms to metal sensitivity based on MELISA results - These associations lack scientific validation 5

When Metal Allergy Testing Is Appropriate

For patients with suspected metal hypersensitivity (contact dermatitis, oral symptoms with dental work, implant reactions):

  • First-line: Patch testing with standardized metal allergens 6
  • Consider testing for nickel, cobalt, chromium, gold, palladium based on exposure history
  • Delayed readings at 48-96 hours are essential 6
  • Clinical correlation is mandatory - positive tests without clinical symptoms do not require intervention

MELISA has no established role in clinical practice and should not be used for diagnostic or treatment decisions.

References

Research

Validity of MELISA for metal sensitivity testing.

Neuro endocrinology letters, 2003

Research

MELISA-an in vitro tool for the study of metal allergy.

Toxicology in vitro : an international journal published in association with BIBRA, 1994

Guideline

drug allergy: a 2022 practice parameter update.

Journal of Allergy and Clinical Immunology, 2022

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.